AMC075: A sequential phase I/randomized phase II trial of vorinostat and risk-adapted chemotherapy with rituximab in HIV-related B-cell non-Hodgkin's lymphoma

Category Primary study
JournalJournal of Clinical Oncology
Year 2011
This article has no abstract
Epistemonikos ID: 31221a33f6caefc28b20ea9d7b88b12059f3ef52
First added on: Feb 04, 2025